A modification of the APC resistance test and its application to the study of patients on coumarin therapy
- 1 May 1996
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 82 (3) , 217-224
- https://doi.org/10.1016/0049-3848(96)00068-0
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Resistance to Activated Protein C, the Arg506 to Gin Mutation in the Factor V Gene, and Venous ThrombosisThrombosis and Haemostasis, 1995
- New Molecular Insights into the Genetics of Thrombophilia. Resistance to Activated Protein C Caused by Arg506 to Gin Mutation in Factor V as a Pathogenic Risk Factor for Venous ThrombosisThrombosis and Haemostasis, 1995
- Modified test for activated protein C resistanceThe Lancet, 1994
- Resistance to activated protein c: Evaluation of three functional assaysThrombosis Research, 1994
- Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosisThe Lancet, 1994
- Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor VThe Lancet, 1994
- Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophiliaBlood, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Anticoagulant protein C pathway defective in majority of thrombophilic patients [see comments]Blood, 1993